Hepsin has been described to promote cancer progression and metastasis in a mouse model (Klezovitch et al, 2004), but it seems to inhibit cell growth and invasion in prostate cancer cells (Srikantan et al, 2002). Here, HPN is linked to prostate carcinoma.